Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers

Recruiting

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

Australia

Scientia Clinical Research Ltd., Randwick, New South Wales

Phase

Safety & dosing

Sponsor

Traws Pharma, Inc.

Enrollment target

~24 participants

Started

March 2026

Primary completion

September 2026

Age range

18 Years – 65 Years

Last updated on clinicaltrials.gov in April 2026.

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Ekaterina Dokukina

Traws Pharma, Inc.